Trials / Completed
CompletedNCT03496103
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
Induction of Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- The University of Texas Medical Branch, Galveston · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
In this study subjects self recorded nasal and ocular symptoms scores from exposure to ragweed pollen in an Allergen Challenge Chamber (ACC). This single site study of seasonal allergic rhinitis was designed to enroll up to 35 participants. These participants would be age 18-70, male and female, with a mixture of ethnic groups. The study would involve 2 phases: Screening and Exposure. In the Exposure phase, participants were exposed to pollen for up to 180 minutes.
Detailed description
This was a study to evaluate self recorded nasal and ocular allergy symptom scores from exposure to ragweed pollen in an Allergen Challenge Chamber (ACC). This single site study of seasonal allergic rhinitis was designed to enroll up to 35 participants. These participants would be age 18-70, male and female, with a mixture of ethnic groups. The study would involve 2 phases: Screening and Exposure. In the Exposure phase, participants were exposed to pollen for up to 180 minutes. For allergic participants, qualification symptom scores at 120 minutes of exposure determined if ACC exposure would be continued.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ragweed pollen | three hours ragweed pollen in a allergen exposure chamber |
Timeline
- Start date
- 2016-02-29
- Primary completion
- 2016-03-12
- Completion
- 2016-03-12
- First posted
- 2018-04-12
- Last updated
- 2018-04-12
Source: ClinicalTrials.gov record NCT03496103. Inclusion in this directory is not an endorsement.